ASSESSMENT OF AN ISOTHIAZOLE THIOSEMICARBAZONE IN THE PROPHYLAXIS OF CONTACTS OF VARIOLA MAJOR
- 14 May 1966
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 287 (7446) , 1072-1074
- https://doi.org/10.1016/s0140-6736(66)91013-0
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- AN ISOTHIAZOLE THIOSEMICARBAZONE IN THE TREATMENT OF VARIOLA MAJOR IN MAN: A Controlled Clinical Trial and Laboratory InvestigationsThe Lancet, 1966
- Antiviral Chemotherapy. II. Structure-Activity Relationships in a Series of Isothiazolealdehyde and Ketone Thiosemicarbazones1aJournal of Medicinal Chemistry, 1965
- THE LABORATORY AND CLINICAL ASSESSMENT OF AN ISOTHIAZOLE THIOSEMICARBAZONE (M & B 7714) AGAINST POX VIRUSESAnnals of the New York Academy of Sciences, 1965
- A New Antiviral Agent : 4-Bromo-3-methylisothiazole-5-carboxaldehyde thiosemicarbazone, M and B 7714Nature, 1964
- CONTROLLED TRIAL OF MARBORAN ON GROUP VACCINATED AGAINST SMALLPOXThe Lancet, 1964
- PROPHYLACTIC TREATMENT OF SMALLPOX CONTACTS WITH N-METHYLISATIN β-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN)The Lancet, 1963
- Activity of p-Aminobenzaldehyde, 3-Thiosemicarbazone on Vaccinia Virus in the Chick Embryo and in the MouseExperimental Biology and Medicine, 1950